Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Doxycycline Prophylaxis for Prevention of STIs Among Young African Women
NCT07884240Phase 3Not yet recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2026
- Primary completion
- Sep 2028
- Countries
- 4
01
Overview
A Phase 3 trial of doxycycline in sexually transmitted infection (STI), gonorrhea, syphilis, Chlamydia trachomatis infection (CT), sponsored by National Institute of Allergy and Infectious Diseases. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
sexually transmitted infection (STI)gonorrheasyphilisChlamydia trachomatis infection (CT)
Beyond the preview
Go deeper on NCT07884240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07884240.